The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
Open accessAbstract
BACKGROUND: Previous studies indicate that disulfiram (DS), an anti-alcoholism drug, is cytotoxic to cancer cell lines and reverses anticancer drug resistance. Cancer stem cells (CSCs) are the major cause of chemoresistance leading to the failure of cancer chemotherapy. This study intended to examine the effect of DS on breast cancer stem cells (BCSCs). METHODS: The effect of DS on BC cell lines and BCSCs was determined by MTT, western blot, CSCs culture and CSCs marker analysis. RESULTS: Disulfiram was highly toxic to BC cell lines in vitro in a copper (Cu)-dependent manner. In Cu-containing medium (1 μM), the IC(50) concentrations of DS in BC cell lines were 200-500 nM. Disulfiram/copper significantly enhanced (3.7-15.5-fold) cytotoxicity of paclitaxel (PAC). Combination index isobologram analysis demonstrated a synergistic effect between DS/Cu and PAC. The increased Bax and Bcl2 protein expression ratio indicated that intrinsic apoptotic pathway may be involved in DS/Cu-induced apoptosis. Clonogenic assay showed DS/Cu-inhibited clonogenicity of BC cells. Mammosphere formation and the ALDH1(+VE) and CD24(Low)/CD44(High) CSCs population in mammospheres were significantly inhibited by exposure to DS/Cu for 24 h. Disulfiram/copper induced reactive oxygen species (ROS) generation and activated its downstream apoptosis-related cJun N-terminal kinase and p38 MAPK pathways. Meanwhile, the constitutive NFκB activity in BC cell lines was inhibited by DS/Cu. CONCLUSION: Disulfiram/copper inhibited BCSCs and enhanced cytotoxicity of PAC in BC cell lines. This may be caused by simultaneous induction of ROS and inhibition of NFκB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,537
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
Junttila, M. R., Li, S., & Westermarck, J. (2008) · The FASEB Journal · doi:10.1096/fj.06-7859rev · Cited by 826
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Marchitti, S. A., Brocker, C., Stagos, D., & Vasiliou, V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.697 · Cited by 805
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy
López-Lázaro, M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.029 · Cited by 715
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Plumb, J. A., Milroy, R., & Kaye, S. B. (1989) · PubMed · Cited by 579
Marcato, P., Dean, C. A., Pan, D., Araslanova, R., Gillis, M., Joshi, M., Helyer, L., Pan, L., Leidal, A., Gujar, S., et al. (2011) · Stem Cells · doi:10.1002/stem.563 · Cited by 483
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Landen, C. N., Goodman, B., Katre, A. A., Steg, A. D., Nick, A. M., Stone, R. L., Miller, L. D., Mejia, P. V., Jennings, N. B., Gershenson, D. M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0563 · Cited by 382
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites
Johansson, B. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03310.x · Cited by 349
Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Jin, Y., Lu, Z., Ding, K., Li, J., Du, X., Chen, C., Sun, X., Wu, Y., Zhou, J., & Pan, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3950 · Cited by 322
Copper and Zinc levels in normal and malignant tissues
Margalioth, E. J., Schenker, J. G., & Chevion, M. (1983) · Cancer · doi:10.1002/1097-0142(19830901)52:5<868::aid-cncr2820520521>3.0.co;2-k · Cited by 301
Nobel, C. S. I., Kimland, M., Lind, B., Orrenius, S., & Slater, A. F. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26202 · Cited by 280
Marchitti, S. A., Deitrich, R. A., & Vasiliou, V. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.1 · Cited by 280
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
Sládek, N. E. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10057 · Cited by 266
Iljin, K., Ketola, K., Vainio, P., Halonen, P., Kohonen, P., Fey, V., Grafström, R. C., Perälä, M., & Kallioniemi, O. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1035 · Cited by 240
Wang, W., McLeod, H. L., & Cassidy, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10972 · Cited by 226
Self-citationThe Actions and Metabolic Fate of Disulfiram
Eneanya, D. I., Bianchine, J. R., Duran, D. O., & Andresen, B. D. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.003043 · Cited by 217
Comparison between concentrations of trace elements in normal and neoplastic human breast tissue.
Rizk, S. L., & Sky‐Peck, H. H. (1984) · PubMed · Cited by 209
Rausch, V., Liu, L., Kallifatidis, G., Baumann, B., Mattern, J., Gladkich, J., Wirth, T., Schemmer, P., Büchler, M. W., Zöller, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0066 · Cited by 209
Storci, G., Sansone, P., Mari, S., D'Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 189
ALDH3A1: a corneal crystallin with diverse functions
Estey, T., Piatigorsky, J., Lassen, N., & Vasiliou, V. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.010 · Cited by 154
Disulfiram induces apoptosis in human melanoma cells: a redox-related process.
Cen, D., Gonzalez, R. I., Buckmeier, J. A., Kahlon, R. S., Tohidian, N. B., & Meyskens, F. L. (2002) · PubMed · Cited by 146
Guo, X., Xu, B., Pandey, S., Goessl, E., Brown, J. E. P., Armesilla, A. L., Darling, J. L., & Wang, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.002 · Cited by 138
Self-citationYang, C. H., Gonzalez-Angulo, A. M., Reuben, J. M., Booser, D. J., Pusztai, L., Krishnamurthy, S., Esseltine, D. L., Stec, J. J., Broglio, K. R., Islam, R., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj131 · Cited by 135
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Alison, M. R., Guppy, N., Lim, S. M. L., & Nicholson, L. J. (2010) · The Journal of Pathology · doi:10.1002/path.2772 · Cited by 131
Trace-Metal Analysis of Cancerous and Non-cancerous Human Tissues 2
Mulay, I. L., Roy, R., Knox, B. E., Suhr, N. H., & Delaney, W. E. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/47.1.1 · Cited by 126
Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells
Wang, W., Cassidy, J., O’Brien, V., Ryan, K. M., & Collie-Duguid, E. S. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0970 · Cited by 120
Self-citationZhang, X., Frezza, M., Milacic, V., Ronconi, L., Fan, Y., Bi, C., Fregona, D., & Dou, Q. P. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22394 · Cited by 111
Wickström, M., Danielsson, K., Rickardson, L., Gullbo, J., Nygren, P., Isaksson, A., Larsson, R. L., & Lövborg, H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.016 · Cited by 109
Morrison, B. W., Doudican, N. A., Patel, K. R., & Orlow, S. J. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e328334131d · Cited by 106
Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
Wang, W., Marsh, S., Cassidy, J., & McLeod, H. L. (2001) · PubMed · Cited by 76
Self-citationLam, J. P., Mays, D. C., & Lipsky, J. J. (1997) · Biochemistry · doi:10.1021/bi970948e · Cited by 69
Marques, D. S., Sandrini, J. Z., Boyle, R. T., Marins, L. F., & Trindade, G. S. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.11.004 · Cited by 51
Xu, B., Guo, X., Mathew, S., Armesilla, A. L., Cassidy, J., Darling, J. L., & Wang, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.013 · Cited by 49
Self-citationPhase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours
Cresta, S., Sessa, C., Catapano, C. V., Gallerani, E., Passalacqua, D., Rinaldi, A., Bertoni, F., Viganò, L., Maur, M., Capri, G., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.022 · Cited by 35
Kast, R. E., & Belda-Iniesta, C. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789649241 · Cited by 32
The Effect of Copper Compounds upon the Growth of Carcinoma in the Rat
Hieger, I. (1926) · Biochemical Journal · doi:10.1042/bj0200232 · Cited by 16
Cited by
Copper induces cell death by targeting lipoylated TCA cycle proteins
Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022) · Science · doi:10.1126/science.abf0529 · Cited by 4,932
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807
Mechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Ahamed, M., Akhtar, J., Kumar, Khan, M., Ahmad, & Alrokayan (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29129 · Cited by 701
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Metadata
- Authors
- Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W.
- Venue
- British Journal of Cancer
- Published
- 2011-04-12
- Volume
- 104
- Issue
- 10
- Pages
- 1564-1574
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2045208621
- Cited by
- 421
- References
- 51
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.